ArticleBiology2026
Computational Protein Redesign of Bacteriophages by Using Evolutionary Algorithms.
Article in Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Protein-protein interactions are a fundamental component of most biological processes in living organisms. Therefore, enhancing these molecular interactions is of major importance in the life sciences field. In this paper we present the redesign of a protein-protein complex using single-elitist and multi-objective evolutionary algorithms. We focus on a structural complex composed of a bacteriophage protein interacting with a bacterial protein, emphasizing the interaction zone, which is defined by the closest distance between residues from proteins and comprises thirty-eight positions. Our approach fuses physics-based energy calculations with data-driven models to maximize the effectiveness of the search process. By simultaneously minimizing interaction energy and maximizing the log-likelihood ratio, the proposed algorithms show a balance between thermodynamic stability and biological sequence plausibility. This hybrid strategy guides the mutation of specific residues, enabling the identification of optimal solutions that are both physically robust and evolutionarily relevant. Results demonstrate that the evolved Pareto optimal set exhibits a significant improvement in binding affinity, with mean interface energy decreasing from +32 to -60 REU (Rosetta Energy Units). Furthermore, the analysis identifies key conserved residue positions, validating the capability of the framework to produce energetically favorable and biologically consistent protein designs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.